Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project

July 27, 2018 updated by: Fondation Lenval

The purpose of the JEMImE project is to create a serious game to help children with Autism and Pervasive Developmental Disorder (PDD) develop facial and vocal emotions in context.

The objective of this study is to record facial and vocal emotional productions in children with autism and PDD in order to create an algorithm for the recognition of facial emotional expressions implemented in the serious game JEMImE.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Nice, France, 06200
        • Fondation Lenval Hôpitaux Pédiatriques de Nice CHU-LENVAL
      • Paris, France, 75013
        • Hôpital de La Salpétrière - APHP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of autism and Pervasive developmental disorder according to Diagnostic and Statistical Manual of Mental Disorders IV (DSM IV) criteria using scales (Autism Diagnostic Interview ADI and / or Autism Diagnostic Observation Schedule ADOS).
  • Intelligence Quotient (IQ) = /> 70 (Wechsler Intelligence Scale for Children WISC IV)
  • Subjects and holders of parental authority who have given their informed and written consent
  • Subjects affiliated to social security system.

Exclusion Criteria:

  • Subjects non affiliated to social security system.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Recordings of facial and vocal emotional
Recordings of facial and vocal emotional productions during Children are performing three tasks
Other: Recordings of facial and vocal emotional productions

Children are asked to perform three tasks:

  1. an emotional production on imitation (the child with autism or TED will imitate the emotion expressed by an animated avatar)
  2. an emotional production by mime of the emotion on command (oral and written) without visualizing the model of imitation
  3. Emotional production in context: the child with autism or EFD will describe images forming the story of Frog and as it is read, will produce the appropriate facial and vocal emotions in the context.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Record facial and vocal emotional productions of children of an imitation situation
Time Frame: At baseline
The outcome is the record with a 3D camera in test situations an imitation (facial and facial / vocal) situation of emotion expressed by an animated (on-screen) avatar with assessment of emotional production
At baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Record facial and vocal emotional productions of children in a situation of mime on written request
Time Frame: At baseline
The outcome is the record with a 3D camera in a situation of mime (facial and facial / vocal) on written request (on screen) with assessment of emotional production
At baseline
Record facial and vocal emotional productions of children in a situation of mime on presentation of an image
Time Frame: At baseline
The outcome is the record with a 3D camera in a situation of mime of an emotion on presentation of an image with assessment of emotional production
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fondation Lenval

Investigators

  • Principal Investigator: Sylvie SERRET, MD, Fondation Lenval Hôpitaux Pédiatriques de Nice CHU-LENVAL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2016

Primary Completion (Actual)

July 10, 2017

Study Completion (Actual)

July 10, 2017

Study Registration Dates

First Submitted

February 22, 2017

First Submitted That Met QC Criteria

June 2, 2017

First Posted (Actual)

June 6, 2017

Study Record Updates

Last Update Posted (Actual)

July 31, 2018

Last Update Submitted That Met QC Criteria

July 27, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15-HPNCL-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism

Clinical Trials on Recordings of facial and vocal emotional productions

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe